ZA941645B - Antibodies specifically reactive against human prostate specific antigen. - Google Patents

Antibodies specifically reactive against human prostate specific antigen.

Info

Publication number
ZA941645B
ZA941645B ZA941645A ZA941645A ZA941645B ZA 941645 B ZA941645 B ZA 941645B ZA 941645 A ZA941645 A ZA 941645A ZA 941645 A ZA941645 A ZA 941645A ZA 941645 B ZA941645 B ZA 941645B
Authority
ZA
South Africa
Prior art keywords
specific antigen
against human
human prostate
prostate specific
antibodies specifically
Prior art date
Application number
ZA941645A
Inventor
G P Talwar
Original Assignee
South To South Co Operation In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South To South Co Operation In filed Critical South To South Co Operation In
Priority to ZA941645A priority Critical patent/ZA941645B/en
Publication of ZA941645B publication Critical patent/ZA941645B/en

Links

ZA941645A 1994-03-09 1994-03-09 Antibodies specifically reactive against human prostate specific antigen. ZA941645B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA941645A ZA941645B (en) 1994-03-09 1994-03-09 Antibodies specifically reactive against human prostate specific antigen.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA941645A ZA941645B (en) 1994-03-09 1994-03-09 Antibodies specifically reactive against human prostate specific antigen.

Publications (1)

Publication Number Publication Date
ZA941645B true ZA941645B (en) 1995-01-13

Family

ID=25583741

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA941645A ZA941645B (en) 1994-03-09 1994-03-09 Antibodies specifically reactive against human prostate specific antigen.

Country Status (1)

Country Link
ZA (1) ZA941645B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997002350A1 (en) * 1995-06-30 1997-01-23 Boehringer Mannheim Gmbh Recombinant human prostate specific antigen and uses thereof
WO1997003203A3 (en) * 1995-07-10 1997-04-17 Therion Biolog Corp Generation of immune responses to prostate-specific antigen (psa)
US5820880A (en) * 1995-06-07 1998-10-13 The United States Of America As Represented By The Secretary Of The Army Liposomal formulation
WO2003072789A3 (en) * 2002-02-28 2004-02-12 Medinnova Ges Med Innovationen Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
US7871986B2 (en) * 1996-03-20 2011-01-18 The United States Of America As Represented By The Department Of Health And Human Services Methods of stimulating an immune response against prostate specific antigen

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5820880A (en) * 1995-06-07 1998-10-13 The United States Of America As Represented By The Secretary Of The Army Liposomal formulation
WO1997002350A1 (en) * 1995-06-30 1997-01-23 Boehringer Mannheim Gmbh Recombinant human prostate specific antigen and uses thereof
WO1997003203A3 (en) * 1995-07-10 1997-04-17 Therion Biolog Corp Generation of immune responses to prostate-specific antigen (psa)
EP1162272A3 (en) * 1995-07-10 2004-07-14 Therion Biologics Corporation Generation of immune responses to prostate-specific antigen (SPA)
US7871986B2 (en) * 1996-03-20 2011-01-18 The United States Of America As Represented By The Department Of Health And Human Services Methods of stimulating an immune response against prostate specific antigen
US8178508B2 (en) 1996-03-20 2012-05-15 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Methods of stimulating an immune response against prostate specific antigen
WO2003072789A3 (en) * 2002-02-28 2004-02-12 Medinnova Ges Med Innovationen Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors

Similar Documents

Publication Publication Date Title
IL136335A0 (en) Monoclonal human natural antibodies
IL128406A0 (en) Monoclonal antibodies
PL311926A1 (en) Anti-alphav-integrinic monoclonal antibodies
ZA959336B (en) Antibodies
IL130143A0 (en) Humanized anti-CD11a antibodies
AU1462300A (en) Human pan-hcv human monoclonal antibodies
PL330111A1 (en) Concentyratyed antibody preparation
IL136201A0 (en) TREATMENT WITH ANTI-ErbB2 ANTIBODIES
IL129164A0 (en) Antibody against human parathormone related peptides
AU5365296A (en) Human monoclonal antibody against lung carcinoma
EP0676966A4 (en) Antibodies directed against binding-associated epitopes.
HUP9800613A3 (en) Humanized antibody against human fas-antigene
HUP9800744A3 (en) Antibodies against fas-antigene
EP0977590A4 (en) Human monoclonal antibodies
ZA941645B (en) Antibodies specifically reactive against human prostate specific antigen.
ZA951113B (en) Tumor assosiated monoclonal antibody 123av16
GB9721432D0 (en) Improved production of antibodies through the use of antigen antibody complexes
ZA973643B (en) Metastasis-associated antigen and antibodies thereto.
AU1135595A (en) Saccharomyces-specific antigens and antibodies, their preparation and use
AU4775899A (en) Human monoclonal antibodies against the tumor antigen uk114 and lymphocyte cellsand hybridomas for their production
PL329866A1 (en) Monoclonal antibody against human mp52
GB9316679D0 (en) Antibodies against tumour specific antigens
GB9615027D0 (en) Monoclonal antibodies
IL134049A0 (en) Anti-cryptdin antibodies
GB9415331D0 (en) Antibodies